Wei-Ping He
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Hepatitis C virus research 4
- Liver Disease and Transplantation 4
- Epidemiology 11
- Hepatitis B Virus Studies 10
- Liver Disease Diagnosis and Treatment 6
- Co-authors
- Aimin Zhang (7 shared papers)Zhengsheng Zou (1 shared paper)Jianfei Shi (1 shared paper)Fu‐Sheng Wang (1 shared paper)Ming Shi (1 shared paper)Ruonan Xu (1 shared paper)Zhenwen Liu (1 shared paper)Liming Chen (1 shared paper)
In The Last Decade
Wei-Ping He
28 papers receiving 469 citations
Peers
Comparison fields: 5 of 66
- Hepatology 241
- Genetics 163
- Surgery 186
- Pharmacology 35
- Epidemiology 126
Countries citing papers authored by Wei-Ping He
This map shows the geographic impact of Wei-Ping He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Ping He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Ping He more than expected).
Fields of papers citing papers by Wei-Ping He
This network shows the impact of papers produced by Wei-Ping He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Ping He. The network helps show where Wei-Ping He may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei-Ping He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 276 | |
| 2 | 2019 | 32 | |
| 3 | 2020 | 17 | |
| 4 | 2016 | 16 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 14 | |
| 7 | Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure. | 2012 | 14 |
| 8 | 2018 | 13 | |
| 9 | 2023 | 11 | |
| 10 | 2024 | 10 | |
| 11 | 2016 | 8 | |
| 12 | 2016 | 6 | |
| 13 | [Association between HBV genotype and chronic/severe liver disease with HBV infection in Chinese patients]. | 2010 | 6 |
| 14 | 2021 | 5 | |
| 15 | 2011 | 5 | |
| 16 | [Lamivudine and entecavir significantly improved the prognosis of early-to-mid stage hepatitis B related acute on chronic liver failure]. | 2010 | 5 |
| 17 | 2019 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Wei-Ping He
Wei-Ping He is a scholar working on Hepatology, Epidemiology, Organic Chemistry, Surgery and Molecular Biology, having authored 31 papers that have together received 476 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (4 papers), N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (4 papers), Liver Disease and Transplantation (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Catalytic Cross-Coupling Reactions (3 papers). The work is most often cited by research in Hepatology (241 citations), Genetics (163 citations), Surgery (186 citations), Pharmacology (35 citations) and Epidemiology (126 citations). Wei-Ping He has collaborated with scholars based in China and Ethiopia. Frequent co-authors include Aimin Zhang, Zhengsheng Zou, Jianfei Shi, Fu‐Sheng Wang, Ming Shi, Ruonan Xu, Zhenwen Liu, Liming Chen, Hu Lin and Hua Geng. Their work appears in journals such as Current Organic Synthesis, BMC Cancer, Tetrahedron Letters, Hepatology International and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.